Company / SG&A per Share
MANNKIND CORP SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.48
FY2025
5-year range
$0.32 / $0.48
FY2021-FY2025
Trend
+36.2%
vs FY2024
Sector context
#171 of 208
Health Care
What the data says
MANNKIND CORP's sg&a per share of $0.48 is lower than 82% of companies in the Health Care sector (FY2025). SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $0.48.
Based on SEC 10-K filings.
0.48 in FY2025 with a 5-year CAGR of +11.3%.
Increased from $0.36 to $0.48 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- +11.3%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 208This company $0.48 Sector average $29.78
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 36.2% year-over-year.
- Ranks #171 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2017.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.48 | +36.2% |
| FY2024 | $0.35 | -2.3% |
| FY2023 | $0.36 | -1.7% |
| FY2022 | $0.36 | +13.8% |
| FY2021 | $0.32 | +14.7% |
| FY2020 | $0.28 | -30.2% |
| FY2019 | $0.40 | -40.4% |
| FY2018 | $0.67 | -14.5% |
| FY2017 | $0.78 | +43.1% |
| FY2016 | $0.55 | +442.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026